<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">arthyper</journal-id><journal-title-group><journal-title xml:lang="ru">Артериальная гипертензия</journal-title><trans-title-group xml:lang="en"><trans-title>"Arterial’naya Gipertenziya" ("Arterial Hypertension")</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1607-419X</issn><issn pub-type="epub">2411-8524</issn><publisher><publisher-name>Antihypertensive League</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/1607-419X-2006-12-1-22-31</article-id><article-id custom-type="elpub" pub-id-type="custom">arthyper-1041</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Вазоактивные факторы в патогенезе преэклампсии</article-title><trans-title-group xml:lang="en"><trans-title>Vasoactive factors in the preeclampsia pathogenesis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Резник</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Reznic</surname><given-names>V. ..</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Санкт-Петербургская Государственная Педиатрическая медицинская академия</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2006</year></pub-date><volume>12</volume><issue>1</issue><fpage>22</fpage><lpage>31</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Резник В.А., 2006</copyright-statement><copyright-year>2006</copyright-year><copyright-holder xml:lang="ru">Резник В.А.</copyright-holder><copyright-holder xml:lang="en">Reznic V...</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://htn.almazovcentre.ru/jour/article/view/1041">https://htn.almazovcentre.ru/jour/article/view/1041</self-uri><abstract><p>На сегодня ни одна проблема в акушерстве не вызывает столь пристального внимания как проблема преэклампсии и эклампсии. В общей популяции беременных женщин частота преэклампсии составляет 5-10 %, а эклампсии 0,05 %. В мировой литературе ежегодно публикуется более 1500 научных работ, посвященных различным аспектам этиологии, патогенеза, профилактики и лечения этого осложнения беременности, но многие вопросы так и остаются далекими от разрешения. На сегодняшний день нет единой теории этиологии и патогенеза преэклампсии, что в значительной степени затрудняет своевременную диагностику, оценку степени тяжести и проведение профилактических мероприятий. Данный обзор посвящен изучению роли эндогенных вазоактивных факторов в патогенезе гестационной гипертензии. Кроме того, детально рассмотрена роль эндогенных дигиталисоподобных ингибиторов Na/K-AТФазы (маринобуфагенин) в патогенезе преэклампсии.</p></abstract><trans-abstract xml:lang="en"><p>Preeclampsia-eclampsia is still one oi the leading causes of maternal and fetal morbidity and mortality. Despite active research for many years, the etiology of this disorder exclusive to human pregnancy is enigma. Recent evidence suggests there may be several underlying causes or predispositions leading to the signs of hypertension, proteinuria and edema, findings that allow us to make ithe diagnosis of the «syndrome» of preeclampsia. Despite improved prenatal care, severe preeclampsia and eclampsia still occur. Although understanding of the pal pathophysiology of there disordes has improved, treatment has not changed significantly in over 30 years. Although postponement of delivery in selected women with severe preeclampsia improves fetal outcome to a degree, this is not done without risk to the mot her. The search for the underlying cause of this disorder and for a clinical marker to predict those women who will develop preeclampsia-eclampsia is ongoing, with its prevention the ultimate goal. Moreover, prospective longitudinal studies are needed to better assess the role of circulating angiogenic factors for the identification women at high risk of preeclampsia and the early diagnosis of disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>преэклампсия</kwd><kwd>зклампсия</kwd><kwd>циркулирующие вазоактивные факторы</kwd><kwd>эндотелии</kwd><kwd>предсердный натрийуретический пептид</kwd><kwd>оксид азота</kwd><kwd>вазопрессин</kwd><kwd>маринобуфагенин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>preeclampsia-eclampsia</kwd><kwd>circulating angiogenic factors</kwd><kwd>endothelin</kwd><kwd>atrial natriuretic peptide (APN)</kwd><kwd>nitric oxide</kwd><kwd>vasopressin</kwd><kwd>marinobufagenin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">MacKay A.P., Berg С.J., Afrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 2001; 97:533-538.</mixed-citation><mixed-citation xml:lang="en">MacKay A.P., Berg С.J., Afrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 2001; 97:533-538.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Saftlas A.F., Olson D.R., Franks A.L. et al. Epidemiology of preeclampsia and eclampsia in the United Stales. 1979-1986: Am. J. Obsiet Gynecol. 1990: 163: 460-465.</mixed-citation><mixed-citation xml:lang="en">Saftlas A.F., Olson D.R., Franks A.L. et al. Epidemiology of preeclampsia and eclampsia in the United Stales. 1979-1986: Am. J. Obsiet Gynecol. 1990: 163: 460-465.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Various Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J Obstet. Gynecol. 2000: 183: S1-S21.</mixed-citation><mixed-citation xml:lang="en">Various Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am. J Obstet. Gynecol. 2000: 183: S1-S21.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Crowther C.A. Eclampsia at Harare Maternity Hospital. An epidemiological study. South African Medical Journal, 1985; 68: 927-929.</mixed-citation><mixed-citation xml:lang="en">Crowther C.A. Eclampsia at Harare Maternity Hospital. An epidemiological study. South African Medical Journal, 1985; 68: 927-929.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cunningham E.G., Lindheimer M.D. Hypertension in pregnancy, N. Engl. J. Med, 1992: 326: 927-932.</mixed-citation><mixed-citation xml:lang="en">Cunningham E.G., Lindheimer M.D. Hypertension in pregnancy, N. Engl. J. Med, 1992: 326: 927-932.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Department of Health. Report on Confidential Enquiries into Maternal Deaths in the UK. 1988-90. London: Doll., 1994: 22-33.</mixed-citation><mixed-citation xml:lang="en">Department of Health. Report on Confidential Enquiries into Maternal Deaths in the UK. 1988-90. London: Doll., 1994: 22-33.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Douglas K.A., Redman C.W. Eclampsia in the United Kingdom. British Medical Journal 1994: 309: 1395-1400.</mixed-citation><mixed-citation xml:lang="en">Douglas K.A., Redman C.W. Eclampsia in the United Kingdom. British Medical Journal 1994: 309: 1395-1400.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mac Gillivray J. Some observations on lite Incidence of preeclampsia. J. Obstet Gynaecol. Br. Emp. 1958; 65: 536-539.</mixed-citation><mixed-citation xml:lang="en">Mac Gillivray J. Some observations on lite Incidence of preeclampsia. J. Obstet Gynaecol. Br. Emp. 1958; 65: 536-539.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Eskenazi B., Fenster L., Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991; 266: 237-241.</mixed-citation><mixed-citation xml:lang="en">Eskenazi B., Fenster L., Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA. 1991; 266: 237-241.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Coonrod D.V., Hickok D.E., Zhu K. et al. Risk Jailors for preeclampsia in twin pregnancies: A population-based cohort study. Obsiet. Gynecol, 1995: 85: 645-650.</mixed-citation><mixed-citation xml:lang="en">Coonrod D.V., Hickok D.E., Zhu K. et al. Risk Jailors for preeclampsia in twin pregnancies: A population-based cohort study. Obsiet. Gynecol, 1995: 85: 645-650.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Li O.K., Wi S. Changing paternity and the risk of preeclampsia in the subsequent pregnancy. Am. J. Epidemiol. 2000; 151: 57-62.</mixed-citation><mixed-citation xml:lang="en">Li O.K., Wi S. Changing paternity and the risk of preeclampsia in the subsequent pregnancy. Am. J. Epidemiol. 2000; 151: 57-62.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Trupin L.S., Simon L.P., Eskenazi B. Change in paternity: A risk factor for preeclampsia in multiparas. Epidemiology. 1996; 7: 240-244.</mixed-citation><mixed-citation xml:lang="en">Trupin L.S., Simon L.P., Eskenazi B. Change in paternity: A risk factor for preeclampsia in multiparas. Epidemiology. 1996; 7: 240-244.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Skjaerven R.S., Wilcox A.L., Lie R.T. The interval between pregnancies and the. risk of preeclampsia. N. Engl. J. Med. 2002: 346: 33-38.</mixed-citation><mixed-citation xml:lang="en">Skjaerven R.S., Wilcox A.L., Lie R.T. The interval between pregnancies and the. risk of preeclampsia. N. Engl. J. Med. 2002: 346: 33-38.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bootllard P.Y., Hulsey T.C., Periann J. et al. Association of pregnancу induced hypertension with duration of sexual to habitation before conception. Lancet 1994; 344: 973-975.</mixed-citation><mixed-citation xml:lang="en">Bootllard P.Y., Hulsey T.C., Periann J. et al. Association of pregnancу induced hypertension with duration of sexual to habitation before conception. Lancet 1994; 344: 973-975.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Van Back E., Peeters L.H. Pathogenesis of preeclampsia: A comprehensive model. Obstet. Gynecol. Sun. 1998: 53: 233-239.</mixed-citation><mixed-citation xml:lang="en">Van Back E., Peeters L.H. Pathogenesis of preeclampsia: A comprehensive model. Obstet. Gynecol. Sun. 1998: 53: 233-239.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Van Parnpus M.G., Dekker G.A., Wolf H. et al. High prevalence or hemostatic abnormalities in women «nth a history o/ severe preeclampsia. Am. J. Obstet. Gynecol. 1999: 180: 1146-1150.</mixed-citation><mixed-citation xml:lang="en">Van Parnpus M.G., Dekker G.A., Wolf H. et al. High prevalence or hemostatic abnormalities in women «nth a history o/ severe preeclampsia. Am. J. Obstet. Gynecol. 1999: 180: 1146-1150.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Alsunyman O.M., Castro M.A., Zuckerman E. et al. Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet. Gynecol. 1996; 88, 644-646.</mixed-citation><mixed-citation xml:lang="en">Alsunyman O.M., Castro M.A., Zuckerman E. et al. Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome. Obstet. Gynecol. 1996; 88, 644-646.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Грацианский Н.А., Качалков Д.В., Давыдов С.А. Связь реакции коронарных артерий на внутрикоронарое введение ацетилхолина с факторами риска ишемической болезни сердца. Кардиология. 1999. 39. № 1. С. 25-30.</mixed-citation><mixed-citation xml:lang="en">Грацианский Н.А., Качалков Д.В., Давыдов С.А. Связь реакции коронарных артерий на внутрикоронарое введение ацетилхолина с факторами риска ишемической болезни сердца. Кардиология. 1999. 39. № 1. С. 25-30.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">МсМаhoni P., Smith J. The HELLP syndrome at 16 weeks gestation: possible association with the antiphospholipid syndrome. Aust NZ. J. Obstet. Gynaecol. 1997; 37: 313-314.</mixed-citation><mixed-citation xml:lang="en">МсМаhoni P., Smith J. The HELLP syndrome at 16 weeks gestation: possible association with the antiphospholipid syndrome. Aust NZ. J. Obstet. Gynaecol. 1997; 37: 313-314.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lockwood С.J. Inherited thrombophilias in pregnant patients: Detection and treatment paradigm. Obstet. Gynecol. 2002: 99: 333-341.</mixed-citation><mixed-citation xml:lang="en">Lockwood С.J. Inherited thrombophilias in pregnant patients: Detection and treatment paradigm. Obstet. Gynecol. 2002: 99: 333-341.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Dekker G.A., de Vries L.P., Doelutzsch P.M. et al. Underlying disorders associated with severe early-onset preeclampsia. Am. J Obstet. Gynecol. 1995; 173: 1042-1048.</mixed-citation><mixed-citation xml:lang="en">Dekker G.A., de Vries L.P., Doelutzsch P.M. et al. Underlying disorders associated with severe early-onset preeclampsia. Am. J Obstet. Gynecol. 1995; 173: 1042-1048.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Tyni T., Ekholdm E., Pihko H. Pregnancy complications are frequent In long-chain 3- hydroxylacyl coenzyme A dehydrogenase deficiency. Am. J. Obstet. Gynecol. 1998; 178: 603-608.</mixed-citation><mixed-citation xml:lang="en">Tyni T., Ekholdm E., Pihko H. Pregnancy complications are frequent In long-chain 3- hydroxylacyl coenzyme A dehydrogenase deficiency. Am. J. Obstet. Gynecol. 1998; 178: 603-608.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ibdah J.A., Dasouki M.J., Strauss A.W. Long-chain 3-hydroxyacyl-CaF dehydrogenase deficiency. Variable expressivity of maternal illness during pregnancy and unusual presentation null infantile cholestasis and hypocalcaemia. J. Inhern. Metab. Dis. 1999; 2: 811-814.</mixed-citation><mixed-citation xml:lang="en">Ibdah J.A., Dasouki M.J., Strauss A.W. Long-chain 3-hydroxyacyl-CaF dehydrogenase deficiency. Variable expressivity of maternal illness during pregnancy and unusual presentation null infantile cholestasis and hypocalcaemia. J. Inhern. Metab. Dis. 1999; 2: 811-814.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Treem W.R., Rmaldo P., Hale D.E. et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994; 19: 339-345.</mixed-citation><mixed-citation xml:lang="en">Treem W.R., Rmaldo P., Hale D.E. et al. Acute fatty liver of pregnancy and long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994; 19: 339-345.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Welzka P., Winkler К., Kuiner M. et al. Altered lipid metabolism in preeclampsia and HELLP syndrome: Links in enhanced platelet reactivity and fetal growth. Semin Thromb. Hemost 1999; 25: 455-462.</mixed-citation><mixed-citation xml:lang="en">Welzka P., Winkler К., Kuiner M. et al. Altered lipid metabolism in preeclampsia and HELLP syndrome: Links in enhanced platelet reactivity and fetal growth. Semin Thromb. Hemost 1999; 25: 455-462.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Репина M.A. Преэклампсия и материнская смертность, СПб.: Изд. Дом CIПбMAIIO. 2005.</mixed-citation><mixed-citation xml:lang="en">Репина M.A. Преэклампсия и материнская смертность, СПб.: Изд. Дом CIПбMAIIO. 2005.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rippman E.Т. Organization gestosis. New approaches in terminology, prevention and therapy of gestosis. M., 1997. P. 18-19.</mixed-citation><mixed-citation xml:lang="en">Rippman E.Т. Organization gestosis. New approaches in terminology, prevention and therapy of gestosis. M., 1997. P. 18-19.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Айламазян Э.К. Неотложная помощь при экстремальных состояниях а в акушерской практике: Руководство. - М: Медицина. 1993.</mixed-citation><mixed-citation xml:lang="en">Айламазян Э.К. Неотложная помощь при экстремальных состояниях а в акушерской практике: Руководство. - М: Медицина. 1993.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dekker G.A., Robillard Р.Y., Hulsey Т.С. Immune maladaption in the etiology of preeclampsia: A reviewoaf corroborative epidemiologic studies. Obstet. Gynecol. Sun 1998; 53: 377-382.</mixed-citation><mixed-citation xml:lang="en">Dekker G.A., Robillard Р.Y., Hulsey Т.С. Immune maladaption in the etiology of preeclampsia: A reviewoaf corroborative epidemiologic studies. Obstet. Gynecol. Sun 1998; 53: 377-382.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Graham С.H., Postovil H., Park M.T. et al. Hole of oxygen in the regulation of trophoblast gene expression and invasion. Placenta 2000; 21: 443-450.</mixed-citation><mixed-citation xml:lang="en">Graham С.H., Postovil H., Park M.T. et al. Hole of oxygen in the regulation of trophoblast gene expression and invasion. Placenta 2000; 21: 443-450.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kovats В., Main E.K., Librach C. et al. A class I antigen. HLA-G, expressed in human trophoblast. Science 1990; 248: 220-223.</mixed-citation><mixed-citation xml:lang="en">Kovats В., Main E.K., Librach C. et al. A class I antigen. HLA-G, expressed in human trophoblast. Science 1990; 248: 220-223.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">De Croot C.J., Bloemenkamp K.W., Duvekot E.J. et al. Preeclampsia and genetic risk factors for thrombosis: A case-control study. Am. J. Obstet. Gynecol., 1999; 181: 975-980.</mixed-citation><mixed-citation xml:lang="en">De Croot C.J., Bloemenkamp K.W., Duvekot E.J. et al. Preeclampsia and genetic risk factors for thrombosis: A case-control study. Am. J. Obstet. Gynecol., 1999; 181: 975-980.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Sihai B.M. Prevention of preeclampsia: A big disappointment. Am. J. Obstet Gynecol. 1998; 179: 1275-1278.</mixed-citation><mixed-citation xml:lang="en">Sihai B.M. Prevention of preeclampsia: A big disappointment. Am. J. Obstet Gynecol. 1998; 179: 1275-1278.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Lang R., Pridjian G., Feldman С. et al. Alterations in left ventricular mechanics in preeclampsia: Increased afterload or cardiomyopathy? Am. Heart. J. 1991; 121: 1768-1775.</mixed-citation><mixed-citation xml:lang="en">Lang R., Pridjian G., Feldman С. et al. Alterations in left ventricular mechanics in preeclampsia: Increased afterload or cardiomyopathy? Am. Heart. J. 1991; 121: 1768-1775.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Longo L.D. Maternal blood volume and cardiac output during pregnancy: A hypothesis of endocrinologic control Am. J Physiol. 1983; 245: R720-R729.</mixed-citation><mixed-citation xml:lang="en">Longo L.D. Maternal blood volume and cardiac output during pregnancy: A hypothesis of endocrinologic control Am. J Physiol. 1983; 245: R720-R729.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Lark S.L., Cotton D.B., Pivarnik J.M. et al. Position change mid central hemodynamic profile during norma third-trimester pregnancy and postpartum. Am. J. Obstet. Gynecol. 1991: 164: 883-887.</mixed-citation><mixed-citation xml:lang="en">Lark S.L., Cotton D.B., Pivarnik J.M. et al. Position change mid central hemodynamic profile during norma third-trimester pregnancy and postpartum. Am. J. Obstet. Gynecol. 1991: 164: 883-887.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Podjarny E., Baylis C., Losonezy G. Animal models of preeclampsia. Semite Perinatal 1999; 23: 2-13.</mixed-citation><mixed-citation xml:lang="en">Podjarny E., Baylis C., Losonezy G. Animal models of preeclampsia. Semite Perinatal 1999; 23: 2-13.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Mabie W.C., Di Sessa T.G., Crocker L.G. et all. A longitudinal Study of cardiac output in normal human pregnancy. Am. J. Ohstet. Gynecol. 1994; 170: 849-856.</mixed-citation><mixed-citation xml:lang="en">Mabie W.C., Di Sessa T.G., Crocker L.G. et all. A longitudinal Study of cardiac output in normal human pregnancy. Am. J. Ohstet. Gynecol. 1994; 170: 849-856.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Baylis C., Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial-derived relaxing factor (EDRF) in the rat. Clin. Exp. Hypertens. 1992; B11: 117-129.</mixed-citation><mixed-citation xml:lang="en">Baylis C., Engels K. Adverse interactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial-derived relaxing factor (EDRF) in the rat. Clin. Exp. Hypertens. 1992; B11: 117-129.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Грибкова И.В., Шуберт Р., Серебряков В.И. NО активирует Са2+ активируемый К+ гладкомышечных клеток хвостовой артерии крысы через GMP — зависимый механизм // Кардиология. 2002. № 8. С. 34-37.</mixed-citation><mixed-citation xml:lang="en">Грибкова И.В., Шуберт Р., Серебряков В.И. NО активирует Са2+ активируемый К+ гладкомышечных клеток хвостовой артерии крысы через GMP — зависимый механизм // Кардиология. 2002. № 8. С. 34-37.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Зотова И.В., Затейщиков Д.A., Сидоренко Б.А. Синтез оксида азота и разввитие атеросклероза // Кардиология. № 4, 2003. C. 58-67.</mixed-citation><mixed-citation xml:lang="en">Зотова И.В., Затейщиков Д.A., Сидоренко Б.А. Синтез оксида азота и разввитие атеросклероза // Кардиология. № 4, 2003. C. 58-67.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Seligman S.P., Bayon J.P., Clancy P.M. et all. The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 1994; 171: 944-948.</mixed-citation><mixed-citation xml:lang="en">Seligman S.P., Bayon J.P., Clancy P.M. et all. The role of nitric oxide in the pathogenesis of preeclampsia. Am. J. Obstet. Gynecol. 1994; 171: 944-948.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Khalil R.A., Crews J.K., Novak I et al. Enhanced vascular rem tint у during inhibition of nitric оxide synthesis in pregnant rats. Hypertension. 1998; 31: 1065-1069.</mixed-citation><mixed-citation xml:lang="en">Khalil R.A., Crews J.K., Novak I et al. Enhanced vascular rem tint у during inhibition of nitric оxide synthesis in pregnant rats. Hypertension. 1998; 31: 1065-1069.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Molnar M., Suto T., Toth T. et all. Prolonged blockade of nitric oxide synthesis In gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am. J. Obstet. Gynecol. 1994; 170: 1458-1466.</mixed-citation><mixed-citation xml:lang="en">Molnar M., Suto T., Toth T. et all. Prolonged blockade of nitric oxide synthesis In gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intrauterine growth retardation. Am. J. Obstet. Gynecol. 1994; 170: 1458-1466.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Yallampalli C., Garfield P.P. Inhibition of nitric oxide synthesis in rats during pregnant у produces signs similar to those of preeclampsia. Am. J Obstet. Gynecol. 1993, 169: 1316-1320.</mixed-citation><mixed-citation xml:lang="en">Yallampalli C., Garfield P.P. Inhibition of nitric oxide synthesis in rats during pregnant у produces signs similar to those of preeclampsia. Am. J Obstet. Gynecol. 1993, 169: 1316-1320.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Walsh S.W. Preeclampsia: An imbalance in placenta! Prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 1985: 152: 335-340.</mixed-citation><mixed-citation xml:lang="en">Walsh S.W. Preeclampsia: An imbalance in placenta! Prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 1985: 152: 335-340.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Walsh S.W., Kay H.H. Placental lipid peroxides and thromboxane me increased and prostacyclin is decreased in women with preeclampsia. Am. J Obstet Gynecol. 1992: 167: 946-949.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Walsh S.W., Kay H.H. Placental lipid peroxides and thromboxane me increased and prostacyclin is decreased in women with preeclampsia. Am. J Obstet Gynecol. 1992: 167: 946-949.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Walsh S.W., Guo J. et al. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am. J. Obstet. Gynecol. 1991; 165: 1695-1700.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Walsh S.W., Guo J. et al. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am. J. Obstet. Gynecol. 1991; 165: 1695-1700.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Kangawa K., Matsuo H. Purification and complete amino acid sequence of a-human atrial natriuretic peptide (a-hANP, 22). Biochem Biophys Res Commun 1984; 118: 131-139.</mixed-citation><mixed-citation xml:lang="en">Kangawa K., Matsuo H. Purification and complete amino acid sequence of a-human atrial natriuretic peptide (a-hANP, 22). Biochem Biophys Res Commun 1984; 118: 131-139.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Campese V.M., Wederhom A. M.A. Natriuretic peptides. In: Oparil S., Weber M.A., eds. Hypertension: A Companion to Brenner and Rector's The Kidney. Philadelphia: WB Saunders. 2000. 164-176.</mixed-citation><mixed-citation xml:lang="en">Campese V.M., Wederhom A. M.A. Natriuretic peptides. In: Oparil S., Weber M.A., eds. Hypertension: A Companion to Brenner and Rector's The Kidney. Philadelphia: WB Saunders. 2000. 164-176.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkins M., Redondo J., Brown L. The natriuretic-peptide family. Lancet 1997; 349: 1307-1310.</mixed-citation><mixed-citation xml:lang="en">Wilkins M., Redondo J., Brown L. The natriuretic-peptide family. Lancet 1997; 349: 1307-1310.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">De Bold A.J., Borenstein H.В., Veress A.T. et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981: 28: 89-94.</mixed-citation><mixed-citation xml:lang="en">De Bold A.J., Borenstein H.В., Veress A.T. et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981: 28: 89-94.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Charles C.L., Espinosa P.A., Richards A.M. Cardiovascular actions of ANP: Contributions of renal, neurohumoral and hemodynamic factors in sheep Am. J. Physiol. 1993; 264: R533-538.</mixed-citation><mixed-citation xml:lang="en">Charles C.L., Espinosa P.A., Richards A.M. Cardiovascular actions of ANP: Contributions of renal, neurohumoral and hemodynamic factors in sheep Am. J. Physiol. 1993; 264: R533-538.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Wiedmann P., Hasler L., Gnadinger M.P. et all. Blood levels and renal effects of atrial natriuretic peptide in normal man. J. Clin. Invest. 1986; 77: 734-742.</mixed-citation><mixed-citation xml:lang="en">Wiedmann P., Hasler L., Gnadinger M.P. et all. Blood levels and renal effects of atrial natriuretic peptide in normal man. J. Clin. Invest. 1986; 77: 734-742.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Zafirovska K.G., Maleska V.T., Bogdanovska S.V. et all Plasma human atrial natriuretic peptide, endothelin-1, aldosterone and plasma-renin activity in pregnancy-induced hypertension. J. Hypertens 1999; 17: 1317-1322.</mixed-citation><mixed-citation xml:lang="en">Zafirovska K.G., Maleska V.T., Bogdanovska S.V. et all Plasma human atrial natriuretic peptide, endothelin-1, aldosterone and plasma-renin activity in pregnancy-induced hypertension. J. Hypertens 1999; 17: 1317-1322.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Kitamura К., Kangawа К., Каwamoto M. et al. Adrenumedullin a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Pes. Commun. 1993: 192: 553-560.</mixed-citation><mixed-citation xml:lang="en">Kitamura К., Kangawа К., Каwamoto M. et al. Adrenumedullin a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Pes. Commun. 1993: 192: 553-560.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Ishiyama Y., Kitamura К., Ichiki Y. et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur. J. Pharmacol. 1993; 241: 271-273.</mixed-citation><mixed-citation xml:lang="en">Ishiyama Y., Kitamura К., Ichiki Y. et al. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur. J. Pharmacol. 1993; 241: 271-273.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Minegishi T., Nakamura M., Abe K. et all. Adrenomedullin and atrial natriuretic peptide content ml inns in normal pregnancy preeclampsia. Mol. Hum. Reprod. 1999: 5: 767-770.</mixed-citation><mixed-citation xml:lang="en">Minegishi T., Nakamura M., Abe K. et all. Adrenomedullin and atrial natriuretic peptide content ml inns in normal pregnancy preeclampsia. Mol. Hum. Reprod. 1999: 5: 767-770.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Di Lorio R., Marinoni E., Letitzin С. et al. Adrenomedullin, a new vasoactive peptide, is increased in preeclampcia. Hypertension. 1998: 32: 758-763.</mixed-citation><mixed-citation xml:lang="en">Di Lorio R., Marinoni E., Letitzin С. et al. Adrenomedullin, a new vasoactive peptide, is increased in preeclampcia. Hypertension. 1998: 32: 758-763.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Clark B.A., Halverson L., Sachs B. et al. Plasma endothelin levels in preeclampsia. Evaluation and correlation with levels and renal impairment. Am. J Obstet. Gynecol. 1992; 166: 962-968.</mixed-citation><mixed-citation xml:lang="en">Clark B.A., Halverson L., Sachs B. et al. Plasma endothelin levels in preeclampsia. Evaluation and correlation with levels and renal impairment. Am. J Obstet. Gynecol. 1992; 166: 962-968.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Orbak Z., Zor N., Energin M. et al. Endothelin-1 levels in mothers with eclampsia -preeclampsia and their newborns. Trap. Pediatrr. 1998; 44: 17-19.</mixed-citation><mixed-citation xml:lang="en">Orbak Z., Zor N., Energin M. et al. Endothelin-1 levels in mothers with eclampsia -preeclampsia and their newborns. Trap. Pediatrr. 1998; 44: 17-19.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Kohan D.E. Endothelins in the normal and diseased kidney. Am. J Kidney Dis. 1997, 29: 2-26.</mixed-citation><mixed-citation xml:lang="en">Kohan D.E. Endothelins in the normal and diseased kidney. Am. J Kidney Dis. 1997, 29: 2-26.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Shaarawy M., Abel-Mogid A-M.A. Plasma endolhelin-1 and mean arterial pressure in the prediction of preeclampsia. Seand. J. Clin. Lab. Invest. 1994: 53: 41-49.</mixed-citation><mixed-citation xml:lang="en">Shaarawy M., Abel-Mogid A-M.A. Plasma endolhelin-1 and mean arterial pressure in the prediction of preeclampsia. Seand. J. Clin. Lab. Invest. 1994: 53: 41-49.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Bussen S., Sitterlin M., Steek T. Plasma endothelin and big endothelin levels in women with severe preeclampsia at HELLP syndrome. Arch. Gynecol. Ohstet. 1999: 262: 113-119.</mixed-citation><mixed-citation xml:lang="en">Bussen S., Sitterlin M., Steek T. Plasma endothelin and big endothelin levels in women with severe preeclampsia at HELLP syndrome. Arch. Gynecol. Ohstet. 1999: 262: 113-119.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Dekker G.A., Kraaycnbriuk A.A. et al. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe preeclampsia. Eur. J. Obstet. Cyneco. Reprod. Biol., 1991: 40: 215-220.</mixed-citation><mixed-citation xml:lang="en">Dekker G.A., Kraaycnbriuk A.A. et al. Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe preeclampsia. Eur. J. Obstet. Cyneco. Reprod. Biol., 1991: 40: 215-220.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Schiffrin P.L. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995; 25: 1135-1143.</mixed-citation><mixed-citation xml:lang="en">Schiffrin P.L. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995; 25: 1135-1143.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Singh H.L., Rahman A., Lirmie E.T. et all. Endothelin-1 in fetoplacental tissues from normotensive pregnant women and и women with preeclampsia. Acta. Obstet. Gynecol. Scand. 2001: 80: 99-103.</mixed-citation><mixed-citation xml:lang="en">Singh H.L., Rahman A., Lirmie E.T. et all. Endothelin-1 in fetoplacental tissues from normotensive pregnant women and и women with preeclampsia. Acta. Obstet. Gynecol. Scand. 2001: 80: 99-103.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor R.N., Varma M., Teng N.H. Et all. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J. Clin. Endocrinol. Metab. 1990: 71: 675-1677.</mixed-citation><mixed-citation xml:lang="en">Taylor R.N., Varma M., Teng N.H. Et all. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J. Clin. Endocrinol. Metab. 1990: 71: 675-1677.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Napolitano M., Miceli F., Calace A. et all. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible / endothelial nitric oxide synthase rnRNA isoforms from normal and preeclamptic placentas. J. Clin. Endocrinol. Metab. 2000; 85: 2318-2323.</mixed-citation><mixed-citation xml:lang="en">Napolitano M., Miceli F., Calace A. et all. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible / endothelial nitric oxide synthase rnRNA isoforms from normal and preeclamptic placentas. J. Clin. Endocrinol. Metab. 2000; 85: 2318-2323.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Goodfrient T.L. Angiotensins actions and receptors. In Hypertension S. Oparil, M. Weber 2000, 11-13.</mixed-citation><mixed-citation xml:lang="en">Goodfrient T.L. Angiotensins actions and receptors. In Hypertension S. Oparil, M. Weber 2000, 11-13.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Weber M.A. Angiotensin II receptor blockers. In hypertensia S. Oparil, 2000, 377-378.</mixed-citation><mixed-citation xml:lang="en">Weber M.A. Angiotensin II receptor blockers. In hypertensia S. Oparil, 2000, 377-378.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Weir M.R. Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers. Current Hypertension Reports. 2002: 4: 333-335.</mixed-citation><mixed-citation xml:lang="en">Weir M.R. Opportunities for cardiovascular risk reduction with angiotensin II receptor blockers. Current Hypertension Reports. 2002: 4: 333-335.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Моисеев С.В. Блокаторы ангиотензиновых или b-адренорецепторов при артериальной гипертонии. По материалам исследования LIFE. Клиническая фармакология и терапия. 2002. 11 (4): C. 58-62.</mixed-citation><mixed-citation xml:lang="en">Моисеев С.В. Блокаторы ангиотензиновых или b-адренорецепторов при артериальной гипертонии. По материалам исследования LIFE. Клиническая фармакология и терапия. 2002. 11 (4): C. 58-62.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Charles C.L., Espinosa E.A., Richards A.M. Cardiovascular actions of ANF: Contributions of renal, neurohumoral and hemodynamic factors in sheep Am. J. Physiol. 1993: 264: R533-538.</mixed-citation><mixed-citation xml:lang="en">Charles C.L., Espinosa E.A., Richards A.M. Cardiovascular actions of ANF: Contributions of renal, neurohumoral and hemodynamic factors in sheep Am. J. Physiol. 1993: 264: R533-538.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Yundle T.G. Biochemistry of natriuretic peptides. J Intern. Med. 1994; 235: 561-576.</mixed-citation><mixed-citation xml:lang="en">Yundle T.G. Biochemistry of natriuretic peptides. J Intern. Med. 1994; 235: 561-576.</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Kleinert H.O., Maack T., Atlas S.A. et all. Atrial natriuretic factor inhibits angiotensin, norepinephrine and potassium induced vascular contractility. Hypertension 1984; 6: 1-5.</mixed-citation><mixed-citation xml:lang="en">Kleinert H.O., Maack T., Atlas S.A. et all. Atrial natriuretic factor inhibits angiotensin, norepinephrine and potassium induced vascular contractility. Hypertension 1984; 6: 1-5.</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Blaustein M. P. Physiological effects of endogenous ouabain control of intracellular Ca-2+ stores and cell responsiveness. Am. J. Physiol. 1994; 264, C. 1367-1387.</mixed-citation><mixed-citation xml:lang="en">Blaustein M. P. Physiological effects of endogenous ouabain control of intracellular Ca-2+ stores and cell responsiveness. Am. J. Physiol. 1994; 264, C. 1367-1387.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Bagrov A.Y., Fedorova O.V., Dmitrieva R.I., Howald W.N., Hunter A.P., Kuznetsova E.A., Shpen V.M. Characterization of a urinary bufodienolide Na+,K+ -ATPase inhibitor in patients after acute myocardial infarction. Hypertension. 1998; 31; 1097-103.</mixed-citation><mixed-citation xml:lang="en">Bagrov A.Y., Fedorova O.V., Dmitrieva R.I., Howald W.N., Hunter A.P., Kuznetsova E.A., Shpen V.M. Characterization of a urinary bufodienolide Na+,K+ -ATPase inhibitor in patients after acute myocardial infarction. Hypertension. 1998; 31; 1097-103.</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova O.V., Kolodkin N.L., Agalakova N.I., Lakatta E.G. Bagrov A.Y. Marinobufagenin and endogenous alpha-1 sodium pump ligand, in hypertensive. Dahl sah sensitive rats. Hypertension. 2001; 37: 462-466.</mixed-citation><mixed-citation xml:lang="en">Fedorova O.V., Kolodkin N.L., Agalakova N.I., Lakatta E.G. Bagrov A.Y. Marinobufagenin and endogenous alpha-1 sodium pump ligand, in hypertensive. Dahl sah sensitive rats. Hypertension. 2001; 37: 462-466.</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Periyasamy S.M., Liu J., Tanta F., Kabak В., Wakefield В., Malhotra P., Kennedy D.J., Nadoor A., Fedorova O.V., Gunning W., Xie Z. Bagrov A.Y., Shapiro J.L. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int. 2005; 67: 1868-1877.</mixed-citation><mixed-citation xml:lang="en">Periyasamy S.M., Liu J., Tanta F., Kabak В., Wakefield В., Malhotra P., Kennedy D.J., Nadoor A., Fedorova O.V., Gunning W., Xie Z. Bagrov A.Y., Shapiro J.L. Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int. 2005; 67: 1868-1877.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova O.V., Bagrov A.Y. Inhibition of Na/K ATPase from rat aorta by two endogenous Na/K pump inhibitors, ouabain and marinobufagenin. Evidence of interaction with different alpha-subinit isoforms. Am. J. Hypertens. 1997; 10: 929-935.</mixed-citation><mixed-citation xml:lang="en">Fedorova O.V., Bagrov A.Y. Inhibition of Na/K ATPase from rat aorta by two endogenous Na/K pump inhibitors, ouabain and marinobufagenin. Evidence of interaction with different alpha-subinit isoforms. Am. J. Hypertens. 1997; 10: 929-935.</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Gonick H.C., Ding Y., Vaziri N.D., Bagrov A.Y., Fedorova O.V. Simultaneous measurement of marinobufagenin. ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens. 1998; 20: 617-627.</mixed-citation><mixed-citation xml:lang="en">Gonick H.C., Ding Y., Vaziri N.D., Bagrov A.Y., Fedorova O.V. Simultaneous measurement of marinobufagenin. ouabain, and hypertension-associated protein in various disease states. Clin Exp Hypertens. 1998; 20: 617-627.</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova O.V., Talan M.L., Agalakova N.L., Lakatta E.G., Bagrov A.Y. Endogenous ligand of alpha (l) sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation. 2002; 105: 1122-1127.</mixed-citation><mixed-citation xml:lang="en">Fedorova O.V., Talan M.L., Agalakova N.L., Lakatta E.G., Bagrov A.Y. Endogenous ligand of alpha (l) sodium pump, marinobufagenin, is a novel mediator of sodium chloride-dependent hypertension. Circulation. 2002; 105: 1122-1127.</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Лопатин Д.Л. Роль эндогенного дигоксиноподобного фактора маринобуфагенина, в патогенезе гестола. Дисс. … канд. мед. наук. Сиб. 2001.</mixed-citation><mixed-citation xml:lang="en">Лопатин Д.Л. Роль эндогенного дигоксиноподобного фактора маринобуфагенина, в патогенезе гестола. Дисс. … канд. мед. наук. Сиб. 2001.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Lopatin D.A., Ailamazian E.K., Dmitreeva R.I., Shpen V.M., Fedorova O.V., Doris P.A., Bagrov A.Y. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J. Hypertension 17. 1999; 1179-1187.</mixed-citation><mixed-citation xml:lang="en">Lopatin D.A., Ailamazian E.K., Dmitreeva R.I., Shpen V.M., Fedorova O.V., Doris P.A., Bagrov A.Y. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J. Hypertension 17. 1999; 1179-1187.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Fedorova O.V., Kolodkin N.L., Agalakova N.L., Namikas A.R., Bzhelyansky A., St- Louis J., Lakatta E.G., Bagrov A.Y. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 2005; 23: 835-842.</mixed-citation><mixed-citation xml:lang="en">Fedorova O.V., Kolodkin N.L., Agalakova N.L., Namikas A.R., Bzhelyansky A., St- Louis J., Lakatta E.G., Bagrov A.Y. Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake. J Hypertens 2005; 23: 835-842.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Vu H.U., Lanosi-Irimie M.R., Pridjian C.A., Whitbred J.M., Durst J.M. Bagrov A.Y., Fedorova О.V., Pridjian P.G. Puschett J.В. The involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005; 25: 520-528.</mixed-citation><mixed-citation xml:lang="en">Vu H.U., Lanosi-Irimie M.R., Pridjian C.A., Whitbred J.M., Durst J.M. Bagrov A.Y., Fedorova О.V., Pridjian P.G. Puschett J.В. The involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005; 25: 520-528.</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Goodlin R.C. Antigidoxin antibodies in eclampsia. New Engl J Med. 1988: 318: 518-519.</mixed-citation><mixed-citation xml:lang="en">Goodlin R.C. Antigidoxin antibodies in eclampsia. New Engl J Med. 1988: 318: 518-519.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Adair C.D., Buckalew V., Taylor K., Ernest J.M., Frye A.M., Evans C., Veille J.С. Elevated endoxin-like factor complicating a middlefetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996; 16: 529-531.</mixed-citation><mixed-citation xml:lang="en">Adair C.D., Buckalew V., Taylor K., Ernest J.M., Frye A.M., Evans C., Veille J.С. Elevated endoxin-like factor complicating a middlefetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996; 16: 529-531.</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">Adair D., Hinshaw A., Russell G., Rose J., Veille J., Buckalew V. Effects of Fab digoxin-specific antibodies on mean arterial pressure in severe preeclampsia. Am J Hypertens 1997; 10: 11A.</mixed-citation><mixed-citation xml:lang="en">Adair D., Hinshaw A., Russell G., Rose J., Veille J., Buckalew V. Effects of Fab digoxin-specific antibodies on mean arterial pressure in severe preeclampsia. Am J Hypertens 1997; 10: 11A.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
